1219-Glioblastoma Organoids for Precision Oncology

Paper Talk · Jul 2, 2026 · 22m

This research introduces patient-derived glioblastoma organoids (GBOs) as a powerful tool for advancing personalized medicine and improving clinical outcomes for brain cancer patients. These three-dimensional models effectively mirror the histopathological and genetic profiles of the original tumors, offering a more accurate representation than traditional cell cultures. The study demonstrates that drug sensitivity testing using GBOs predicts patient survival and treatment response more reliably than current molecular markers like MGMT methylation. By utilizing this platform, researchers…